News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
464,237 Results
Type
Article (25361)
Company Profile (139)
Press Release (438737)
Section
Business (136259)
Career Advice (1583)
Deals (23554)
Drug Delivery (57)
Drug Development (50323)
Employer Resources (116)
FDA (11759)
Job Trends (10128)
News (225314)
Policy (18547)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (6)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (5)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2060)
Academic (1)
Accelerated approval (2)
Adcomms (6)
Allergies (57)
Alliances (40373)
ALS (55)
Alzheimer's disease (858)
Antibody-drug conjugate (ADC) (79)
Approvals (11772)
Artificial intelligence (246)
Autoimmune disease (10)
Automation (11)
Bankruptcy (167)
Best Places to Work (8497)
BIOSECURE Act (12)
Biosimilars (41)
Biotechnology (98)
Bladder cancer (36)
Brain cancer (16)
Breast cancer (166)
Cancer (1304)
Cardiovascular disease (113)
Career advice (1305)
Career pathing (22)
CAR-T (115)
Cell therapy (300)
Cervical cancer (15)
Clinical research (40790)
Collaboration (641)
Compensation (127)
Complete response letters (7)
COVID-19 (1886)
CRISPR (40)
C-suite (154)
Cystic fibrosis (64)
Data (1353)
Decentralized trials (1)
Denatured (22)
Depression (22)
Diabetes (155)
Diagnostics (5477)
Digital health (15)
Diversity (6)
Diversity, equity & inclusion (32)
Drug discovery (92)
Drug pricing (51)
Drug shortages (19)
Duchenne muscular dystrophy (48)
Earnings (46423)
Editorial (17)
Employer branding (16)
Employer resources (103)
Events (64203)
Executive appointments (462)
FDA (12536)
Featured Employer (33)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (2)
Funding (545)
Gene editing (89)
Generative AI (23)
Gene therapy (209)
GLP-1 (409)
Government (2314)
Grass and pollen (3)
Guidances (32)
Healthcare (13388)
Huntington's disease (10)
IgA nephropathy (17)
Immunology and inflammation (54)
Indications (17)
Infectious disease (1983)
Inflammatory bowel disease (95)
Inflation Reduction Act (5)
Influenza (35)
Intellectual property (63)
Interviews (272)
IPO (10090)
IRA (26)
Job creations (1975)
Job search strategy (1092)
Kidney cancer (5)
Labor market (17)
Layoffs (184)
Leadership (12)
Legal (3853)
Liver cancer (48)
Lung cancer (171)
Lymphoma (80)
Machine learning (3)
Management (38)
Manufacturing (197)
MASH (45)
Medical device (12157)
Medtech (12162)
Mergers & acquisitions (13841)
Metabolic disorders (371)
Multiple sclerosis (56)
NASH (16)
Neurodegenerative disease (46)
Neuropsychiatric disorders (7)
Neuroscience (1162)
NextGen: Class of 2025 (4743)
Non-profit (2804)
Northern California (1419)
Now hiring (11)
Obesity (172)
Opinion (127)
Ovarian cancer (46)
Pain (64)
Pancreatic cancer (49)
Parkinson's disease (92)
Partnered (17)
Patents (146)
Patient recruitment (66)
Peanut (36)
People (41023)
Pharmaceutical (27)
Pharmacy benefit managers (10)
Phase I (12275)
Phase II (17885)
Phase III (14058)
Pipeline (678)
Podcasts (45)
Policy (66)
Postmarket research (1490)
Preclinical (5226)
Press Release (67)
Prostate cancer (60)
Psychedelics (12)
Radiopharmaceuticals (191)
Rare diseases (214)
Real estate (4108)
Recruiting (46)
Regulatory (13553)
Reports (27)
Research institute (1844)
Resumes & cover letters (315)
Rett syndrome (4)
RNA editing (2)
RSV (35)
Schizophrenia (28)
Series A (109)
Series B (60)
Service/supplier (10)
Sickle cell disease (30)
Southern California (1393)
Special edition (7)
Spinal muscular atrophy (101)
Sponsored (18)
Startups (2939)
State (2)
Stomach cancer (6)
Supply chain (35)
Tariffs (4)
The Weekly (22)
United States (13645)
Vaccines (498)
Venture capitalists (23)
Webinars (9)
Weight loss (100)
Women's health (23)
Worklife (11)
Date
Today (27)
Last 7 days (424)
Last 30 days (1691)
Last 365 days (22230)
2025 (5488)
2024 (23591)
2023 (27565)
2022 (37267)
2021 (39991)
2020 (38226)
2019 (33866)
2018 (25602)
2017 (23710)
2016 (22787)
2015 (26493)
2014 (19446)
2013 (16049)
2012 (17384)
2011 (18075)
2010 (16113)
Location
Africa (527)
Alabama (40)
Alaska (7)
Arizona (141)
Arkansas (11)
Asia (29972)
Australia (5328)
California (3460)
Canada (1222)
China (303)
Colorado (170)
Connecticut (170)
Delaware (62)
Europe (66629)
Florida (526)
Georgia (161)
Idaho (40)
Illinois (329)
India (16)
Indiana (199)
Iowa (6)
Japan (121)
Kansas (86)
Kentucky (12)
Louisiana (7)
Maine (23)
Maryland (531)
Massachusetts (2448)
Michigan (194)
Minnesota (279)
Mississippi (2)
Missouri (64)
Montana (26)
Nebraska (20)
Nevada (32)
New Hampshire (66)
New Jersey (1096)
New Mexico (20)
New York (1095)
North Carolina (598)
North Dakota (7)
Northern California (1419)
Ohio (121)
Oklahoma (14)
Oregon (22)
Pennsylvania (733)
Puerto Rico (8)
Rhode Island (21)
South America (769)
South Carolina (18)
South Dakota (1)
Southern California (1393)
Tennessee (67)
Texas (500)
Utah (111)
Virginia (74)
Washington D.C. (18)
Washington State (386)
West Virginia (3)
Wisconsin (38)
464,237 Results for "umbra applied technologies group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
BioMidwest
UAT Group Subsidiary, Ossifix Orthopedics Begins Comparative Study
Umbra Applied Technologies Group, Inc. announce that its subsidiary, Ossifix Orthopedics has begun a comparative study with doctors across six different sites.
January 20, 2023
·
4 min read
Press Releases
Global Hemp Group Announces Private Placement and Corporate Update
March 18, 2025
·
5 min read
Business
Agilent Names Philip Binns to Lead Life Sciences and Applied Markets Group
Agilent Technologies, Inc. (NYSE: A) today announced Philip Binns has been named president of the company’s Life Sciences and Applied Markets Group (LSAG).
September 5, 2023
·
1 min read
Press Releases
Pharming Group to participate in April 2024 investor conferences
March 28, 2025
·
1 min read
Complete response letters
Applied Therapeutics Crashes After FDA Rejection of Rare Disease Drug
After extending its review period to evaluate additional submissions, the FDA ultimately denied Applied Therapeutics’ govorestat for galactosemia, citing “deficiencies” with the application. The biotech plans to meet with the regulator to discuss the best way forward for the drug.
December 2, 2024
·
3 min read
·
Tristan Manalac
Regulatory
FDA Warns Applied Therapeutics of ‘Objectionable Conditions’ in Govorestat Study
The agency’s warning letter outlines Applied Therapeutics’ failure to provide adequate information regarding the clinical trial—including a dosing error for govorestat—claims that the company said it had already addressed.
December 4, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
March 25, 2025
·
3 min read
BioMidwest
UAT Group Subsidiary, The Dreaming Company Announces Hygieia Eye Gel
Umbra Applied Technologies Group, Inc. announced that its subsidiary, The Dreaming Company, is expanding on its Hygieia product line with the launch of a new premium revitalizing eye gel.
August 2, 2022
·
4 min read
BioMidwest
UAT Group Subsidiary, Ossifix Orthopedics, Launching Demineralized Bone Matrix Product
Umbra Applied Technologies Group, Inc. announced that its subsidiary Ossifix Orthopedics has added a new product to its expanding suite of orthopedic products.
July 19, 2022
·
4 min read
1 of 46,424
Next
